• News & Events
  • Resources
  • Careers
  • Investors
Aptar Logo
  • Products
  • business areas
  • Services
  • ESG
  • About Aptar
Pharmaceutical, Case Studies

Case Study - Ophthalmic Squeeze Dispenser and ESG

31 Oct 2022

With around 70% of the world economy now covered by net zero targets, and recent research suggesting that 80% of consumers want to see less plastic packaging, post-pandemic, there is an urgent need for more sustainable pharmaceutical solutions.

This case study compares the packaging weight and associated Global Warming Potential (GWP) of Aptar Pharma’s Ophthalmic Squeeze Dispenser (OSD), a multi-dose preservative-free eye dropper, with the widely used delivery format of Blow-Fill-Seal (BFS) single use vials. By reducing the amount of primary packaging material used and minimizing medication waste the OSD multi-dose preservative-free eyedropper delivers a more sustainable pharmaceutical solution for eyecare, with a lower GWP.

Aptar Pharma is committed to developing sustainable pharmaceutical solutions by, for example, maximizing the use of renewable energies, effective recycling, and innovative product design. The OSD multi-dose preservative-free eye dropper exemplifies the progress already made.

Share
Ophthalmic-Squeeze-Dispenser_vs_Blow-Fill-Seal_Updated.jpg

Learn more about Ophthalmic Squeeze Dispenser

Find out more about OSD

This Might Also Be of Interest

18 Dec 2023
Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery

Pharmaceutical Publications
13 Mar 2023
Moving Towards Greater Recyclability in Drug Delivery - Sustainable Solutions by Aptar Pharma

Pharmaceutical Webinars
14 Dec 2022
Building Digital Solutions To Meet The Unique Therapeutic Needs of Patients

Pharmaceutical Publications
09 Nov 2022
Sustainability Measures Are the Key to Meeting ESG Commitments

Pharmaceutical Publications